Cargando…

Increased Effector Memory Insulin-Specific CD4(+) T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes

Type 1 diabetes (T1D) results from T cell–mediated destruction of insulin-producing β-cells. Insulin represents a key self-antigen in disease pathogenesis, as recent studies identified proinsulin-responding T cells from inflamed pancreatic islets of organ donors with recent-onset T1D. These cells re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spanier, Justin A., Sahli, Nathanael L., Wilson, Joseph C., Martinov, Tijana, Dileepan, Thamotharampillai, Burrack, Adam L., Finger, Erik B., Blazar, Bruce R., Michels, Aaron W., Moran, Antoinette, Jenkins, Marc K., Fife, Brian T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2017
Materias:	Immunology and Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697953/ https://www.ncbi.nlm.nih.gov/pubmed/28842400 http://dx.doi.org/10.2337/db17-0666

Ejemplares similares

Distinguishing Persistent Insulin Autoantibodies With Differential Risk: Nonradioactive Bivalent Proinsulin/Insulin Autoantibody Assay
por: Yu, Liping, et al.
Publicado: (2012)

T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
por: Burrack, Adam L., et al.
Publicado: (2017)

Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
por: Osum, Kevin C., et al.
Publicado: (2018)

Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3
por: Mamchak, Alusha A., et al.
Publicado: (2012)

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes
por: Baker, Rocky L., et al.
Publicado: (2019)

Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes
por: Fourlanos, Spiros, et al.
Publicado: (2011)

Insulin Transactivator MafA Regulates Intrathymic Expression of Insulin and Affects Susceptibility to Type 1 Diabetes
por: Noso, Shinsuke, et al.
Publicado: (2010)

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation
por: Xipell, Marc, et al.
Publicado: (2018)

PD-1 pathway-mediated regulation of islet-specific CD4(+) T cell subsets in autoimmune diabetes
por: Martinov, Tijana, et al.
Publicado: (2016)

B-1a Lymphocytes Attenuate Insulin Resistance
por: Shen, Lei, et al.
Publicado: (2015)

Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes
por: Acevedo-Calado, Maria J., et al.
Publicado: (2019)

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience
por: Maurer, Katie, et al.
Publicado: (2021)

Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01
por: Arribas-Layton, David, et al.
Publicado: (2020)

T-Cell Costimulation Protects Obesity-Induced Adipose Inflammation and Insulin Resistance
por: Zhong, Jixin, et al.
Publicado: (2014)

Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD
por: Bruce, Danny W., et al.
Publicado: (2021)

Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance
por: Moraes-Vieira, Pedro M., et al.
Publicado: (2016)

Donor bone marrow–derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice
por: Adams, Rachael C., et al.
Publicado: (2022)

Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency to Be Crucial for Diabetes Protection
por: Fousteri, Georgia, et al.
Publicado: (2010)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Peritransplant Varicosis After Simultaneous Pancreas and Kidney Transplantation Is an Uncommon Cause of Late-Onset and Recurrent Gastrointestinal Bleeding
por: Pfister, Matthias, et al.
Publicado: (2023)

Zinc transporter 8 autoantibody testing requires age-related cut-offs
por: Grace, Sian Louise, et al.
Publicado: (2021)

Activation status dictates the function of unlicensed natural killer cells in mice and humans
por: Aguilar, Ethan G., et al.
Publicado: (2021)

Germline TRAV5D-4 T-Cell Receptor Sequence Targets a Primary Insulin Peptide of NOD Mice
por: Nakayama, Maki, et al.
Publicado: (2012)

A Prospective Study of Renal Transplant Recipients: A Fall in Insulin Secretion Underpins Dysglycemia After Renal Transplantation
por: Langsford, David, et al.
Publicado: (2016)

Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8(+) T Cells
por: Pearson, James A., et al.
Publicado: (2016)

Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2023)

Following the Fate of One Insulin-Reactive CD4 T cell: Conversion Into Teffs and Tregs in the Periphery Controls Diabetes in NOD Mice
por: Fousteri, Georgia, et al.
Publicado: (2012)

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
por: Kwon, Bum Chul, et al.
Publicado: (2022)

Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis
por: Williams, MacKenzie D., et al.
Publicado: (2021)

Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes: A Twin and Population Study
por: Beyan, Huriya, et al.
Publicado: (2012)

Increased Expression of CCL2 in Insulin-Producing Cells of Transgenic Mice Promotes Mobilization of Myeloid Cells From the Bone Marrow, Marked Insulitis, and Diabetes
por: Martin, Andrea P., et al.
Publicado: (2008)

Improvement of compliance to the Portland intensive insulin therapy during liver transplantation after introducing an application software: a retrospective single center cohort study
por: Choi, Young Woong, et al.
Publicado: (2022)

Anti-Islet Autoantibodies Trigger Autoimmune Diabetes in the Presence of an Increased Frequency of Islet-Reactive CD4 T Cells
por: Silva, Diego G., et al.
Publicado: (2011)

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
por: Williams, Alistair J.K., et al.
Publicado: (2015)

Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes
por: Sarkar, Suparna A., et al.
Publicado: (2012)

Deficiency in B7-H1 (PD-L1)/PD-1 Coinhibition Triggers Pancreatic β-Cell Destruction by Insulin-Specific, Murine CD8 T-Cells
por: Rajasalu, Tarvo, et al.
Publicado: (2010)

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA(1c), and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
por: Haller, Michael J., et al.
Publicado: (2019)

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
por: Cutler, Corey, et al.
Publicado: (2021)

Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection
por: Clotet-Freixas, Sergi, et al.
Publicado: (2021)

Assessment and Management of Anti-Insulin Autoantibodies in Varying Presentations of Insulin Autoimmune Syndrome
por: Church, David, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s2obr5d6mudh2helmr69s3ero1